Rhinogram

With Rhinogram–you can.

Rhinogram

With Rhinogram–you can.

Closing in 11 days
Chattanooga, TN
Health Tech
Rhinogram is a virtual platform that connects patients with healthcare providers, removing the need for phone screening and long call times. Skip the wait — use Rhinogram instead. HIPAA-compliant and EHR-friendly, the platform uses encryption to keep patients’ text messages, video interactions, and phone calls private. The compliant communication platform is currently in use by over 750 locations, across 50 different healthcare specialties. We believe Rhinogram is the category king of comprehensive collaborative texting.

$146,338

raised
27
Investors
$60M
Valuation
$11.47
Price per Share
$252.34
Min. Investment
Common
Shares Offered
Equity
Offering Type
$1.07M
Offering Max
11
Days Left

$146,338

raised
27
Investors
$60M
Valuation
$11.47
Price per Share
$252.34
Min. Investment
Common
Shares Offered
Equity
Offering Type
$1.07M
Offering Max
11
Days Left

Stack Owner's Bonus & Rewards!

Members get an extra 10% shares in addition to rewards below!

Rewards

Get rewarded for investing more into Rhinogram:

$252+
Investment
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.
$1,000+
Investment
$1,000+
Invest $1,000 to receive 1% bonus shares
$5,000+
Investment
$5,000+
Invest $5,000 to receive 2% bonus shares
$10,000+
Investment
$10,000+
Invest $10,000 to receive 5% bonus shares
$25,000+
Investment
$25,000+
Invest $25,000 to receive 10% bonus shares + Access to Rhinogram’s Investors Club
$50,000+
Investment
$50,000+
Invest $50,000 to receive 15% bonus shares + Access to Rhinogram’s Investors Club + Invitation to In-Person 7th Annual Meeting with Executives

Reasons to Invest

  • Increase efficiency for hospital systems and individual providers: Reduce call volume by up to 70% and increase the ability to handle patient communication loads at a 6:1 patient-provider ratio.
  • Booming market: Telehealth is worth a quarter trillion dollars.
  • Modernize provider-patient communication: Support the development of AI and language translation on the Rhinogram platform.


OVERVIEW


Getting you back to “why” you got into healthcare


We know healthcare providers are overworked, and we’re here to help. At Rhinogram, we believe that healthcare can be seamless and simple for providers. We’re bringing collaborative texting front and center so you can cut down on phone call volume and get back to the work that really matters: caring for patients.  




THE PROBLEM


Healthcare systems are backed up with high call volume


When demand for healthcare systems hits peak service, phone call volume jumps. Staff quickly become overworked and inundated with patients. This leads to staff shortages, burnout, and a declining patient experience.  




THE SOLUTION


Bridging the gap between convenience and compliance


Rhinogram is an all-in-one collaborative texting platform that decreases inbound phone volume by up to 70%. The platform allows patients to opt-in for HIPAA-compliant texting rather than waiting on hold to reach their healthcare providers. This decreases call times for patients and providers, requiring 30% fewer employees.  




Once the patient accepts the text message, they can communicate via SMS/MMS texting. All messages are encrypted for compliance. The patient doesn’t have to download an app or create an account. 


Rhinogram also has features for patients to digitally schedule appointments, sign forms, and pay for services. For healthcare specialists, Rhinogram’s Customer Success Team acts as a content expert in telehealth, providing an entire library of resources to optimize your practice called RhinoUniversity. 


THE MARKET 


Booming market potential with telehealth ranked a quarter-trillion-dollar industry


The healthcare industry is shifting: there’s a greater consumer focus. Telehealth global VC funding reached $15B in the first half of 2021, and has been dubbed a quarter trillion-dollar industry. Health executives are focused on implementing digital tools — 83% of professionals rank this as a top strategic priority.



Rhinogram is unique because it’s designed with all types of healthcare systems in mind. The platform can support larger healthcare systems and single-provider practices. The platform not only provides a place for care-team to patient communication, it also allows for team-member to team-member communication for internal use. 


OUR TRACTION 


Telemedicine shortlist 2022 winner 


We’re proud to share that over 50 different healthcare specialties use Rhinogram, reaching 10M+ patients. We’ve been recognized on the 2022 Telemedicine Shortlist by Capterra and as a highflier in the Winner & Spring G2 2022 reports


We successfully released the features of RhinoForms and RhinoCall to better serve patients, and have 2 patents for our technology. Software reviews recognized us as Frontrunners in Telemedicine 2022.



WHY INVEST


Let’s make healthcare communication efficient 


At Rhinogram, we value quick communication. Let’s trade in call wait times and voice answering machines for HIPAA-complaint SMS/MMS texting. With Rhinogram’s virtual telehealth platform, we’re on a mission to make healthcare efficient and accessible. Help us grow capital to increase our market penetration and develop new app enhancements including AI and language translation features.


*These testimonials may not be representative of the experience of other customers and is not a guarantee of future performance or success.


Superscript
Remove

Offering Summary


Company

:

Rhinogram, Inc

Corporate Address

:

6820 Lee Highway, Chattanooga, TN 37421

Offering Minimum

:

$9,990.37

Offering Maximum

:

$1,069,967.48

Minimum Investment Amount

(per investor)

:

$252.34











Terms


Offering Type

:

Equity

Security Name

:

Non-Voting Common Stock

Minimum Number of Shares Offered

:

871

Maximum Number of Shares Offered

:

93,284

Price per Share

:

$11.47

Pre-Money Valuation

:

$59,997,688.92











*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below. 

Investment Incentives and Bonuses*

Loyalty Bonus (Audience Based Perk):

Selected Rhinogram investors will receive 10% bonus shares.

Time-Based:

Friends and Family Early Birds

Invest within the first 72 hours and receive 15% bonus shares

 

Super Early Bird Bonus

Invest within the first week and receive 10% bonus shares


Early Bird Bonus

Invest within the first two weeks and receive 5% bonus shares

Amount-Based:

$1,000+

Tier 1 

Invest $1,000 to receive 1% bonus shares

 

$5,000+

Tier 2

Invest $5,000 to receive 2% bonus shares

 

$10,000+

Tier 3

Invest $10,000 to receive 5% bonus shares

 

$25,000+

Tier 4

Invest $25,000 to receive 10% bonus shares + Access to Rhinogram’s Investors Club

 

$50,000+

Tier 5

Invest $50,000 to receive 15% bonus shares + Access to Rhinogram’s Investors Club + Invitation to In-Person 7th Annual Meeting with Executives

*All perks occur when the offering is completed.



The 10% Bonus for StartEngine Shareholders

Rhinogram, Inc. will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Non-Voting Common Stock at $11.47 per share, you will receive 110 shares of Non-Voting Common Stock, meaning you'll own 110 shares of Non-Voting Common Stock for $1,147. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investor's eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.


Insider Investment Notice

Officers, directors, executives, and existing owners with a controlling stake in the company (or their immediate family members) may make investments in this offering. Any such investments will be included in the raised amount reflected on the campaign page.


The Company will not incur any irregular use of proceeds.


Show More
Most recent fiscal year-end:
Prior fiscal year-end:
Total Assets
$3,112,278.00 USD
$4,487,129.00 USD
Cash And Cash Equivalents
$86,086.00 USD
$136,884.00 USD
Accounts Receivable
$0.00 USD
$0.00 USD
Short Term Debt
$0.00 USD
$105,000.00 USD
Long Term Debt
$17,345,200.00 USD
$13,474,965.00 USD
Revenues And Sales
$1,796,794.00 USD
$1,346,238.00 USD
Costs Of Goods Sold
$1,072,344.00 USD
$862,082.00 USD
Taxes Paid
$0.00 USD
$0.00 USD
Net Income
-$5,616,085.00 USD
-$7,059,952.00 USD

Risks

A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.


Updates

Listen to Rhinogram Founder Dr. Dressler on The Podcast by KevinMD

about 2 months ago

Dr. Keith Dressler is Dr. Kevin Pho's guest on the most recent episode of his top-rated podcast. Dr. Dressler frames the pain points for patients and providers in the current healthcare model and the solution he designed - Rhinogram.  He shares his story and discusses his KevinMD article, 3 reasons practices should implement patient-initiated collaborative texting.

Listen at Apple, Spotify, and everywhere you get your podcasts.  


Rhinogram About Us Infographic

2 months ago

Take a tour of Rhinogram via this handy infographic that details our mission, the benefits of Rhinogram's platform to healthcare systems, the reasons healthcare systems love us and the specific connections our platform facilitates at every step in the patient journey.  

Good News! The house passes bill extending Telehealth flexibilities to 2024.

2 months ago

There's more good news about telehealth on our blog. It's what we all wanted, and it's a WIN-WIN for healthcare systems that can provide dynamic, more effective,  compliant, billable care. 

Read more about the bill here.

Thanks for helping us hit over $145,000!

2 months ago

We are so grateful for your support and investment into changing healthcare for good. Thank you for your continued support and congratulations on being a part of the important next phase of Rhinogram!


Thank you to all who have invested! Check out this message from Rhinogram's CEO, Dr. Keith Dressler

2 months ago

Thank you to all who have invested in our company so far! Through hard work, determination and persistence, we are so excited to be live on StartEngine and grow our investor community. 

I truly enjoy sharing successes with everyone who has contributed to the current growth of Rhinogram to date. Together we are changing the future of healthcare for good.

Please share our campaign with your friends and family 

With gratitude,

Dr. Keith Dressler

Is Crowdfunding a Great Option for Health IT Companies?

2 months ago

What do you think? We are excited to share this article about our raise, written by John Lynn.
https://www.healthcareittoday.com/2022/07/18/is-crowdfunding-a-great-option-for-health-it-companies/

Rhinogram Launches Crowdfunding Campaign with StartEngine

2 months ago

Check out the press release for our Start Engine campaign launch. Thank you to everyone so far who has invested in the future of healthcare! https://www.rhinogram.com/post/rhinogram-launches-crowdfunding-campaign-with-startengine

Show More Updates End of Updates

Comments ({{profileCtrl.startup.comments_count}} total)

{{profileCtrl.newComment.body.length}}/2500
Please sign in to post a comment.
Please use Updates for communications.
{{ profileCtrl.commentsLoading ? 'Loading...' : 'Show More Comments' }}